SPONTANEOUS REGRESSION OF METASTATIC RENAL-CELL CARCINOMA FOLLOWING PALLIATIVE IRRADIATION OF THE PRIMARY TUMOR

被引：34

作者：

MACMANUS, MP

HARTE, RJ

STRANEX, S

机构：

[1] Northern Ireland Centre for Clinical Oncology, Belvoir Park Hospital, Belfast, BT8 8JR, Hospital Road

来源：

IRISH JOURNAL OF MEDICAL SCIENCE | 1994年 / 163卷 / 10期

关键词：

D O I：

10.1007/BF02940567

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 58 years old man presented with a bulky renal primary tumour, paratracheal lymphadenopathy and multiple pulmonary metastases. Spontaneous regression of intrathoracic metastases occurred after low dose palliative irradiation of the primary tumour. Serum levels of Interleukin-2 receptor were elevated during the period of tumour regression but concentrations of other cytokines were normal. Progressive abdominal disease eventually caused death. Autopsy confirmed the presence of renal cell carcinoma with intrathoracic metastases.

引用

页码：461 / 463

页数：3

共 16 条

[1]

Everson T.C., Cole W.M., Spontaneous Regression of Cancer, pp. 11-87, (1966)

[2]

Bloom H.J.G., Hormone induced and spontaneous regression of metastatic cancer, Cancer, 32, pp. 1066-1071, (1983)

[3]

Montie J.E., Stewart B.H., Straffon R.A., Et al., The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma, J. Urol., 117, pp. 272-275, (1977)

[4]

Muss H.B., Renal cell carcinoma, Biologic therapy of cancer, pp. 298-311, (1991)

[5]

West W.H., Continuous infusion recombinant interleukin2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignancies, Cancer Treatment Reviews, 16, pp. 83-89, (1989)

[6]

Neidhart J.A., Interferon therapy for the treatment of renal cancer, Cancer, 57, pp. 1696-1699, (1986)

[7]

Atzpodien J., Korfer A., Franks C., Et al., Home therapy with recombinant interleukin-2 and interferon alpha2b in advanced human malignancies, Lancet, 335, pp. 1509-1512, (1990)

[8]

Fairlamb D.J., Spontaneous regression of metastases of renal cancer. A report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literature, Cancer, 47, pp. 2101-2106, (1981)

[9]

Kjaer M., The role of medroxyprogesterone acetate (MPA) in the treatment of advanced renal adenocarcinoma, Cancer Treatment Reviews, 15, pp. 195-209, (1988)

[10]

Marcus S.G., Choyke P.L., Reiter R., Et al., Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy, J. Urol., 150, pp. 463-6, (1993)

← 1 2 →